Spots Global Cancer Trial Database for isotretinoin
Every month we try and update this database with for isotretinoin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia | NCT00003619 | Chronic Myelopr... Leukemia Myelodysplastic... Thrombocytopeni... | filgrastim vitamin E busulfan cytarabine etoposide fludarabine pho... isotretinoin topotecan hydro... bone marrow abl... peripheral bloo... | 19 Years - 90 Years | National Cancer Institute (NCI) | |
| Erlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant Glioma | NCT01103375 | Adult Anaplasti... Adult Anaplasti... Adult Diffuse A... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Adult Oligodend... Recurrent Adult... | erlotinib hydro... isotretinoin laboratory biom... protein express... | 18 Years - | Wake Forest University Health Sciences | |
| Efficacy and Safety of Oral Isotretinoin for the Treatment of Facial Recalcitrant Flat Warts | NCT04290572 | Flat Wart | Isotretinoin ca... | 18 Years - 40 Years | Centro Dermatológico Dr. Ladislao de la Pascua | |
| Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma | NCT00567567 | Localized Resec... Localized Unres... Recurrent Neuro... Regional Neurob... Stage 4 Neurobl... Stage 4S Neurob... | Autologous Hema... Carboplatin Cisplatin Cyclophosphamid... Doxorubicin Hyd... Etoposide External Beam R... Filgrastim Isotretinoin Laboratory Biom... Melphalan Peripheral Bloo... Pharmacological... Thiotepa Topotecan Hydro... Vincristine Sul... | - 30 Years | Children's Oncology Group | |
| Aflac ST1001 Prolonged Isotretinoin | NCT01319838 | Neuroblastoma | Isotretinoin | - 30 Years | Emory University | |
| Isotretinoin, Interferon Alfa-2b, Docetaxel, and Estramustine in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy | NCT00176527 | Prostate Cancer | recombinant int... docetaxel estramustine ph... isotretinoin polyacrylamide ... protein express... immunohistochem... | 18 Years - | Rutgers, The State University of New Jersey | |
| Observation, Combination Chemotherapy, Radiation Therapy, and/or Autologous Stem Cell Transplant in Treating Young Patients With Neuroblastoma | NCT00410631 | Neuroblastoma | filgrastim carboplatin cisplatin cyclophosphamid... dacarbazine doxorubicin hyd... etoposide phosp... ifosfamide isotretinoin melphalan topotecan hydro... vincristine sul... vindesine autologous hema... conventional su... peripheral bloo... iobenguane I 13... radiation thera... | - 21 Years | National Cancer Institute (NCI) | |
| A Study of the Effect of Hu3F8/GM-CSF Immunotherapy Plus Isotretinoin in Patients in First Remission of High-Risk Neuroblastoma | NCT03033303 | Neuroblastoma | Hu3F8 GM-CSF Isotretinoin | - | Memorial Sloan Kettering Cancer Center | |
| Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET | NCT00392327 | Anaplastic Medu... Medulloblastoma | Carboplatin Cisplatin Cyclophosphamid... Filgrastim Isotretinoin Laboratory Biom... Quality-of-Life... Radiation Thera... Vincristine Sul... | 3 Years - 21 Years | Children's Oncology Group | |
| Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma | NCT00004188 | Neuroblastoma | filgrastim carboplatin cisplatin cyclophosphamid... doxorubicin hyd... etoposide isotretinoin melphalan topotecan hydro... vincristine sul... autologous bone... bone marrow abl... conventional su... peripheral bloo... radiation thera... | - 30 Years | Children's Oncology Group | |
| Combination Chemotherapy With or Without Filgrastim Before Surgery, High-Dose Chemotherapy, and Radiation Therapy Followed by Isotretinoin With or Without Monoclonal Antibody in Treating Patients With Neuroblastoma | NCT00030719 | Neuroblastoma | filgrastim monoclonal anti... busulfan carboplatin cyclophosphamid... etoposide isotretinoin melphalan vincristine sul... bone marrow abl... conventional su... peripheral bloo... radiation thera... | 1 Year - 20 Years | National Cancer Institute (NCI) | |
| Phase II Study Of Roferon and Accutane For Patients With T-Cell Malignancies | NCT00038376 | Lymphoma, T-Cel... Mycosis Fungoid... Hematologic Neo... | Isotretinoin (A... Interferon Alph... | 18 Years - | M.D. Anderson Cancer Center | |
| Oral Isotretinoin Versus Topical Tretinoin for Actinic Keratosis | NCT02278861 | Actinic Keratos... | Oral isotretino... Tretinoin 0,05%... Sunscreen FPS 6... | 50 Years - 75 Years | Universidade Federal de Goias | |
| Isotretinoin, Interferon Alpha-2b, and Paclitaxel in Stage IV, Recurrent, or Persistent Cervical Cancer | NCT00138151 | Cervical Cancer | recombinant int... isotretinoin paclitaxel | 18 Years - | Rutgers, The State University of New Jersey | |
| Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma | NCT03786783 | Ganglioneurobla... High Risk Neuro... | Autologous Hema... Carboplatin Cisplatin Cyclophosphamid... Dexrazoxane Dinutuximab Doxorubicin Etoposide External Beam R... Isotretinoin Melphalan Sargramostim Thiotepa Topotecan Vincristine | - 30 Years | National Cancer Institute (NCI) | |
| Belinostat and Isotretinoin in Treating Patients With Solid Tumors That Are Metastatic or That Cannot Be Removed by Surgery | NCT00334789 | Adult Solid Neo... | Belinostat Isotretinoin Pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma | NCT00026312 | Localized Resec... Localized Unres... Recurrent Neuro... Regional Neurob... Stage 4 Neurobl... Stage 4S Neurob... | Aldesleukin Dinutuximab Isotretinoin Laboratory Biom... Pharmacological... Quality-of-Life... Sargramostim | - 30 Years | National Cancer Institute (NCI) | |
| Vitamin E in Preventing the Side Effects of Isotretinoin in Former and Current Smokers Who Are Receiving Isotretinoin to Prevent Lung Cancer | NCT00003599 | Lung Cancer | Vitamin E (AT) Isotretinoin | 18 Years - | M.D. Anderson Cancer Center | |
| Combination Chemotherapy Followed by Stem Cell Transplant and Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma | NCT00526318 | Neuroblastoma | filgrastim carboplatin cisplatin cyclophosphamid... dacarbazine doxorubicin hyd... etoposide phosp... ifosfamide isotretinoin melphalan topotecan hydro... vincristine sul... vindesine autologous hema... iobenguane I 13... radiation thera... | - 21 Years | National Cancer Institute (NCI) | |
| High-Dose Chemotherapy Plus Autologous Stem Cell Transplantation Compared With Intermediate-Dose Chemotherapy Plus Autologous Stem Cell Transplantation With or Without Isotretinoin in Treating Young Patients With Recurrent High-Grade Gliomas | NCT00078988 | Brain Tumor Central Nervous... | filgrastim carboplatin etoposide isotretinoin thiotepa autologous bone... peripheral bloo... | - 20 Years | Children's Oncology Group | |
| Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma | NCT00939965 | Neuroblastoma | isotretinoin DNA analysis polymerase chai... laboratory biom... pharmacological... | - 18 Years | National Cancer Institute (NCI) | |
| Biological Therapy Plus Chemotherapy in Treating Patients With Metastatic or Recurrent Kidney Cancer | NCT00003585 | Kidney Cancer | aldesleukin recombinant int... fluorouracil isotretinoin surgical proced... | - | University of New Mexico | |
| Lenalidomide and Dinutuximab With or Without Isotretinoin in Treating Younger Patients With Refractory or Recurrent Neuroblastoma | NCT01711554 | Recurrent Neuro... Refractory Neur... | Dinutuximab Isotretinoin Laboratory Biom... Lenalidomide Pharmacological... | - 21 Years | National Cancer Institute (NCI) | |
| Biological Therapy in Treating Patients With Neuroblastoma That Has Not Responded to Previous Treatment | NCT00089258 | Neuroblastoma | beta-glucan monoclonal anti... sargramostim isotretinoin | - | Memorial Sloan Kettering Cancer Center | |
| Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia | NCT00003405 | Leukemia | recombinant int... amifostine trih... bromodeoxyuridi... cytarabine idarubicin idoxuridine isotretinoin mitoxantrone hy... | 0 Years - 70 Years | Rush University Medical Center | |
| Doxycycline vs Isotretinoin for Acneiform Eruptions of TKI | NCT04864717 | Acneiform Erupt... Cancer, Treatme... | Doxycycline 100... Isotretinoin 40... | 18 Years - | Lady Davis Institute | |
| Vorinostat and Isotretinoin in Treating Patients With High-Risk Refractory or Recurrent Neuroblastoma | NCT01208454 | Localized Unres... Recurrent Neuro... Regional Neurob... Stage 4 Neurobl... Stage 4S Neurob... | Isotretinoin Laboratory Biom... Pharmacological... Vorinostat | - 30 Years | National Cancer Institute (NCI) | |
| Aflac ST1001 Prolonged Isotretinoin | NCT01319838 | Neuroblastoma | Isotretinoin | - 30 Years | Emory University | |
| Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme | NCT00112502 | Brain and Centr... Glioblastoma Mu... | Celecoxib Isotretinoin Temozolomide Thalidomide | 18 Years - | M.D. Anderson Cancer Center | |
| Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GMCSF) and Isotretinoin for Consolidation of Patients With High-Risk Neuroblastoma in First Remission. | NCT04909515 | Neuroblastoma | Naxitamab GM-CSF Isotretinoin | 1 Year - | Y-mAbs Therapeutics | |
| Induction Chemotherapy Using Cyclophosphamide and Topotecan in Treating Patients Who Are Undergoing Autologous Peripheral Stem Cell Transplantation for Newly Diagnosed or Progressive Neuroblastoma | NCT00070200 | Neuroblastoma | filgrastim cisplatin cyclophosphamid... doxorubicin hyd... etoposide isotretinoin melphalan topotecan hydro... vincristine sul... conventional su... peripheral bloo... radiation thera... | - 30 Years | Children's Oncology Group | |
| Biological Therapy, Sargramostim, and Isotretinoin in Treating Patients With Relapsed or Refractory Neuroblastoma | NCT01334515 | Recurrent Neuro... | hu14.18-IL2 fus... isotretinoin sargramostim laboratory biom... | 1 Year - 30 Years | Children's Oncology Group | |
| Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia | NCT00003405 | Leukemia | recombinant int... amifostine trih... bromodeoxyuridi... cytarabine idarubicin idoxuridine isotretinoin mitoxantrone hy... | 0 Years - 70 Years | Rush University Medical Center | |
| Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Neuroblastoma | NCT00017368 | Neuroblastoma | filgrastim sargramostim carboplatin cisplatin cyclophosphamid... doxorubicin hyd... etoposide etoposide phosp... ifosfamide isotretinoin melphalan thiotepa vincristine sul... conventional su... peripheral bloo... radiation thera... | - 30 Years | Children's Oncology Group | |
| Vorinostat Combined With Isotretinoin and Chemotherapy in Treating Younger Patients With Embryonal Tumors of the Central Nervous System | NCT00867178 | Medulloblastoma Pineoblastoma Supratentorial ... | 3-Dimensional C... Carboplatin Cisplatin Cyclophosphamid... Etoposide Phosp... Isotretinoin Laboratory Biom... Peripheral Bloo... Thiotepa Vincristine Sul... Vorinostat | 2 Months - 47 Months | National Cancer Institute (NCI) | |
| Isotretinoin, Interferon Alfa, and Vitamin E in Treating Patients With Stage III or Stage IV Head and Neck Cancer | NCT00054561 | Head and Neck C... | recombinant int... vitamin E isotretinoin adjuvant therap... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Belinostat and Isotretinoin in Treating Patients With Solid Tumors That Are Metastatic or That Cannot Be Removed by Surgery | NCT00334789 | Adult Solid Neo... | Belinostat Isotretinoin Pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy With or Without Filgrastim Before Surgery, High-Dose Chemotherapy, and Radiation Therapy Followed by Isotretinoin With or Without Monoclonal Antibody in Treating Patients With Neuroblastoma | NCT00030719 | Neuroblastoma | filgrastim monoclonal anti... busulfan carboplatin cyclophosphamid... etoposide isotretinoin melphalan vincristine sul... bone marrow abl... conventional su... peripheral bloo... radiation thera... | 1 Year - 20 Years | National Cancer Institute (NCI) | |
| Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy | NCT00005847 | Prostate Cancer | recombinant int... estramustine ph... isotretinoin mitoxantrone hy... paclitaxel vinorelbine dit... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Vorinostat and Isotretinoin in Treating Patients With Advanced Kidney Cancer | NCT00324740 | Recurrent Renal... Stage III Renal... Stage IV Renal ... | vorinostat isotretinoin | 21 Years - | National Cancer Institute (NCI) | |
| Monoclonal Antibody Ch14.18, Sargramostim, Aldesleukin, and Isotretinoin After Autologous Stem Cell Transplant in Treating Patients With Neuroblastoma | NCT01041638 | High Risk Neuro... | Aldesleukin Diagnostic Labo... Dinutuximab Isotretinoin Sargramostim | - | National Cancer Institute (NCI) | |
| Interferon Alfa With or Without Isotretinoin in Treating Patients With Metastatic Kidney Cancer | NCT00002737 | Kidney Cancer | recombinant int... chemotherapy isotretinoin | 18 Years - 75 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Treatment With Dinutuximab, Sargramostim (GM-CSF), and Isotretinoin in Combination With Irinotecan and Temozolomide After Intensive Therapy for People With High-Risk Neuroblastoma (NBL) | NCT04385277 | Ganglioneurobla... Neuroblastoma | Biospecimen Col... Bone Marrow Asp... Bone Marrow Bio... Computed Tomogr... Dinutuximab FDG-Positron Em... Iobenguane I-12... Irinotecan Isotretinoin Magnetic Resona... Multigated Acqu... Sargramostim Temozolomide | - 30 Years | Children's Oncology Group | |
| Procarbazine and Isotretinoin in Treating Patients With Recurrent Primary Malignant Gliomas | NCT00003564 | Brain and Centr... | Isotretinoin Procarbazine Hy... | 16 Years - | M.D. Anderson Cancer Center | |
| Therapy for Children With Advanced Stage Neuroblastoma | NCT01857934 | Neuroblastoma | cyclophosphamid... topotecan hu14.18K322A peripheral bloo... surgical resect... cisplatin etoposide doxorubicin vincristine busulfan melphalan peripheral bloo... natural killer ... radiation thera... GM-CSF G-CSF mesna levetiracetam interleukin-2 Isotretinoin CliniMACS | - 18 Years | St. Jude Children's Research Hospital | |
| Biological Therapy in Treating Patients With Neuroblastoma That Has Not Responded to Previous Treatment | NCT00089258 | Neuroblastoma | beta-glucan monoclonal anti... sargramostim isotretinoin | - | Memorial Sloan Kettering Cancer Center | |
| Monoclonal Antibody Ch14.18, Sargramostim, Aldesleukin, and Isotretinoin After Autologous Stem Cell Transplant in Treating Patients With Neuroblastoma | NCT01041638 | High Risk Neuro... | Aldesleukin Diagnostic Labo... Dinutuximab Isotretinoin Sargramostim | - | National Cancer Institute (NCI) | |
| Isotretinoin Plus Dexamethasone in Treating Patients With Multiple Myeloma | NCT00021359 | Multiple Myelom... | dexamethasone isotretinoin | 18 Years - | Fox Chase Cancer Center | |
| Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GMCSF) and Isotretinoin for Consolidation of Patients With High-Risk Neuroblastoma in First Remission. | NCT04909515 | Neuroblastoma | Naxitamab GM-CSF Isotretinoin | 1 Year - | Y-mAbs Therapeutics | |
| Efficacy and Safety of Oral Isotretinoin for the Treatment of Facial Recalcitrant Flat Warts | NCT04290572 | Flat Wart | Isotretinoin ca... | 18 Years - 40 Years | Centro Dermatológico Dr. Ladislao de la Pascua | |
| Oral Isotretinoin Versus Topical Tretinoin for Actinic Keratosis | NCT02278861 | Actinic Keratos... | Oral isotretino... Tretinoin 0,05%... Sunscreen FPS 6... | 50 Years - 75 Years | Universidade Federal de Goias | |
| Combination Chemotherapy Followed by Stem Cell Transplant and Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma | NCT00526318 | Neuroblastoma | filgrastim carboplatin cisplatin cyclophosphamid... dacarbazine doxorubicin hyd... etoposide phosp... ifosfamide isotretinoin melphalan topotecan hydro... vincristine sul... vindesine autologous hema... iobenguane I 13... radiation thera... | - 21 Years | National Cancer Institute (NCI) | |
| Safety and Effectiveness of Giving Isotretinoin to HIV-Infected Women to Treat Cervical Tumors | NCT00001073 | HIV Infections Cervix, Dysplas... | Isotretinoin | 13 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Allogeneic Stem Cell Transplantation Followed By Targeted Immune Therapy In Average Risk Leukemia | NCT01020539 | Acute Myelogeno... Myelodysplastic... Juvenile Myelom... | Fludarabine Busulfan GVHD Prophylaxi... Gemtuzumab Ozog... Anti-Thymocyte ... Isotretinoin | 1 Month - 30 Years | Columbia University | |
| Allogeneic Stem Cell Transplantation Followed By Targeted Immune Therapy In Average Risk Leukemia | NCT01020539 | Acute Myelogeno... Myelodysplastic... Juvenile Myelom... | Fludarabine Busulfan GVHD Prophylaxi... Gemtuzumab Ozog... Anti-Thymocyte ... Isotretinoin | 1 Month - 30 Years | Columbia University | |
| A Study of the Effect of Hu3F8/GM-CSF Immunotherapy Plus Isotretinoin in Patients in First Remission of High-Risk Neuroblastoma | NCT03033303 | Neuroblastoma | Hu3F8 GM-CSF Isotretinoin | - | Memorial Sloan Kettering Cancer Center | |
| Erlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant Glioma | NCT01103375 | Adult Anaplasti... Adult Anaplasti... Adult Diffuse A... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Adult Oligodend... Recurrent Adult... | erlotinib hydro... isotretinoin laboratory biom... protein express... | 18 Years - | Wake Forest University Health Sciences | |
| Efficacy and Safety of Oral Isotretinoin for the Treatment of Facial Recalcitrant Flat Warts | NCT04290572 | Flat Wart | Isotretinoin ca... | 18 Years - 40 Years | Centro Dermatológico Dr. Ladislao de la Pascua | |
| Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer | NCT00002506 | Cervical Cancer Esophageal Canc... Head and Neck C... Lung Cancer Non-melanomatou... Penile Cancer | recombinant int... isotretinoin | 18 Years - | Hoag Memorial Hospital Presbyterian | |
| Monoclonal Antibody Therapy With Sargramostim and Interleukin-2 in Treating Children With Neuroblastoma | NCT00005576 | Disseminated Ne... Recurrent Neuro... Regional Neurob... | monoclonal anti... isotretinoin aldesleukin sargramostim | - 21 Years | National Cancer Institute (NCI) | |
| Vorinostat, Isotretinoin and Temozolomide in Adults With Recurrent Glioblastoma Multiforme (GBM) | NCT00555399 | Glioblastoma Mu... Anaplastic Glio... | Vorinostat Isotretinoin Surgical Resect... Temozolomide | 18 Years - | M.D. Anderson Cancer Center | |
| Lenalidomide and Dinutuximab With or Without Isotretinoin in Treating Younger Patients With Refractory or Recurrent Neuroblastoma | NCT01711554 | Recurrent Neuro... Refractory Neur... | Dinutuximab Isotretinoin Laboratory Biom... Lenalidomide Pharmacological... | - 21 Years | National Cancer Institute (NCI) | |
| Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin | NCT01175356 | Ganglioneurobla... Localized Resec... Localized Unres... Regional Neurob... Stage 4 Neurobl... Stage 4S Neurob... | 3-Dimensional C... Autologous Hema... Busulfan Cisplatin Cyclophosphamid... Doxorubicin Hyd... Etoposide Phosp... External Beam R... In Vitro-Treate... Intensity-Modul... Iobenguane I-13... Isotretinoin Laboratory Biom... Melphalan Pharmacological... Questionnaire A... Therapeutic Con... Topotecan Hydro... Vincristine Sul... | 1 Year - 30 Years | Children's Oncology Group | |
| Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer | NCT00002506 | Cervical Cancer Esophageal Canc... Head and Neck C... Lung Cancer Non-melanomatou... Penile Cancer | recombinant int... isotretinoin | 18 Years - | Hoag Memorial Hospital Presbyterian | |
| Aflac ST1001 Prolonged Isotretinoin | NCT01319838 | Neuroblastoma | Isotretinoin | - 30 Years | Emory University | |
| Procarbazine and Isotretinoin in Treating Patients With Recurrent Primary Malignant Gliomas | NCT00003564 | Brain and Centr... | Isotretinoin Procarbazine Hy... | 16 Years - | M.D. Anderson Cancer Center | |
| Therapy for Children With Advanced Stage Neuroblastoma | NCT01857934 | Neuroblastoma | cyclophosphamid... topotecan hu14.18K322A peripheral bloo... surgical resect... cisplatin etoposide doxorubicin vincristine busulfan melphalan peripheral bloo... natural killer ... radiation thera... GM-CSF G-CSF mesna levetiracetam interleukin-2 Isotretinoin CliniMACS | - 18 Years | St. Jude Children's Research Hospital | |
| Isotretinoin, Interferon Alfa, and Vitamin E in Treating Patients With Stage III or Stage IV Head and Neck Cancer | NCT00054561 | Head and Neck C... | recombinant int... vitamin E isotretinoin adjuvant therap... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Vorinostat and Isotretinoin in Treating Patients With Advanced Kidney Cancer | NCT00324740 | Recurrent Renal... Stage III Renal... Stage IV Renal ... | vorinostat isotretinoin | 21 Years - | National Cancer Institute (NCI) | |
| Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma | NCT00567567 | Localized Resec... Localized Unres... Recurrent Neuro... Regional Neurob... Stage 4 Neurobl... Stage 4S Neurob... | Autologous Hema... Carboplatin Cisplatin Cyclophosphamid... Doxorubicin Hyd... Etoposide External Beam R... Filgrastim Isotretinoin Laboratory Biom... Melphalan Peripheral Bloo... Pharmacological... Thiotepa Topotecan Hydro... Vincristine Sul... | - 30 Years | Children's Oncology Group | |
| ch14.18 Pharmacokinetic Study in High-risk Neuroblastoma | NCT01592045 | Neuroblastoma | ch14.18 -NCI ch14.18-UTC Granulocyte-Mac... Aldesleukin (IL... Isotretinoin | - 8 Years | United Therapeutics |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
